On 4th August, China's Department of Maternal and Child Health of National Health and Family Planning Commission (Department of MCH, NHFPC) and United Nations Population Fund China Office (UNFPA China) held the symposium on "Women’s health through life course and empowerment" successfully in Beijing, which was also jointly co-organized by the National Office for Maternal and Child Health Surveillance and The George Institute, China (TGI China).
On July 30, 2017, the 'Salt Substitute and Stroke Study' (SSaSS) 2017 annual meeting was held in Xiongan New District, Baoding, Hebei Province. More than 40 delegates attended the meeting, reported project progress and shared experiences. Participants included Principal Investigators from China and Australia, local Project Investigators, Project Coordinators, and government officials from the local Health and Family Planning Committee and Centers for Disease Control.
On 26 July, SMARTHealth Diabetes launch event was held successfully in Luquan district, Shijiazhuang, Hebei province. Over 80 participants including Professor Yuxia Ma, Vice-President of school of public health at Hebei Medical University, researchers from The George Institute China, Luquan village doctors and investigators joined the meeting.
A Memorandum of Understanding (MOU) has been signed between The George Institute, China (TGI China) and Guangdong General Hospital. On behalf of the respective parties, Professor Jiyan Chen, Director of Cardiovascular Department of Guangdong General Hospital, and Dr Maoyi Tian, Senior Research Fellow of TGI China, signed the MOU in acknowledgement of the importance of the cooperation.
Researchers from The George Institute for Global Health have been awarded funds from UK’s National Institute for Health Research (NIHR) to address the health challenge of stroke care in India and tackle salt consumption in China.
As one of the largest basal insulin research projects in China, the Observational Registry for Basal Insulin Treatment (ORBIT) project was initiated by the Chinese Diabetes Society (CDS), conducted and managed by The George Institute, China and supported by Sanofi China. ORBIT was launched in 2011 and has successfully published research findings this year after the positive participation of 209 secondary and tertiary hospitals nationwide, hundreds of doctors and follow-up of nearly 20,000 patients with type 2 diabetes for 6 months.